Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59


Re-irradiation of adenoid cystic carcinoma: Analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, Münter MW, Herfarth KK, Debus J.

Radiother Oncol. 2015 Feb;114(2):182-8. doi: 10.1016/j.radonc.2015.01.002. Epub 2015 Jan 29.


IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter MW.

BMC Cancer. 2012 May 2;12:163. doi: 10.1186/1471-2407-12-163.


Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Jensen AD, Krauss J, Potthoff K, Simon C, Nikoghosyan AV, Lossner K, Debus J, Münter MW.

Radiat Oncol. 2012 Apr 2;7:57. doi: 10.1186/1748-717X-7-57.


Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Herfarth KK, Münter MW.

Radiat Oncol. 2011 Nov 2;6:149. doi: 10.1186/1748-717X-6-149.


Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Jensen AD, Krauss J, Weichert W, Bergmann ZP, Freier K, Debus J, Münter MW.

Radiat Oncol. 2011 Sep 23;6:122. doi: 10.1186/1748-717X-6-122.


Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.

Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Münter MW, Jensen AD, Jäkel O, Hoess A, Haberer T, Debus J.

Acta Oncol. 2011 Aug;50(6):784-90. doi: 10.3109/0284186X.2011.584558.


Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.

BMC Cancer. 2011 Jun 24;11:266. doi: 10.1186/1471-2407-11-266.


Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility.

Jensen AD, Nikoghosyan A, Ellerbrock M, Ecker S, Debus J, Münter MW.

Radiother Oncol. 2011 Dec;101(3):383-7. doi: 10.1016/j.radonc.2011.05.017. Epub 2011 Jun 2.


Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).

Jensen AD, Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, Münter MW.

BMC Cancer. 2011 May 22;11:190. doi: 10.1186/1471-2407-11-190.


Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Münter MW.

Radiat Oncol. 2011 Apr 5;6:30. doi: 10.1186/1748-717X-6-30.


Review of clinical experience with ion beam radiotherapy.

Jensen AD, Münter MW, Debus J.

Br J Radiol. 2011 Dec;84 Spec No 1:S35-47. doi: 10.1259/bjr/71511359. Epub 2011 Mar 22. Review.


Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].

Jensen AD, Nikoghosyan A, Hinke A, Debus J, Münter MW.

BMC Cancer. 2011 Feb 15;11:70. doi: 10.1186/1471-2407-11-70.


A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer.

Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter MW.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):590-6. doi: 10.1016/j.ijrobp.2010.10.072. Epub 2011 Feb 8.


Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.

Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6.


Carbon ion therapy for ameloblastic carcinoma.

Jensen AD, Ecker S, Ellerbrock M, Nikoghosyan A, Debus J, Münter MW.

Radiat Oncol. 2011 Feb 6;6:13. doi: 10.1186/1748-717X-6-13.


Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer.

Zwicker F, Roeder F, Hauswald H, Thieke C, Timke C, Schlegel W, Debus J, Münter MW, Huber PE.

Head Neck. 2011 Dec;33(12):1695-702. doi: 10.1002/hed.21663. Epub 2011 Jan 31.


Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial.

Jensen AD, Münter MW, Bischoff HG, Haselmann R, Haberkorn U, Huber PE, Thomas M, Debus J, Herfarth KK.

Cancer. 2011 Jul 1;117(13):2986-94. doi: 10.1002/cncr.25888. Epub 2011 Jan 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk